ASRT Stock Recent News

LAKE FOREST, Ill., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT) announced that members of its management team will host investor meetings at two investor conferences in New York City during September 2025.

ASRT, BSM and JJSF have been added to the Zacks Rank #5 (Strong Sell) List on August 26, 2025.

PHILADELPHIA , Aug. 25, 2025 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC  is investigating securities fraud claims against Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) ("Spectrum" or the "Company") on behalf of investors who purchased or otherwise acquired common shares of Spectrum between  March 17, 2022 through September 22, 2022 (the "Class Period"). Investor Deadline:  Investors who purchased or acquired Spectrum securities during the Class Period may, no later than September 24, 2025 , seek to be appointed as a lead plaintiff representative of the class.

PHILADELPHIA , Aug. 19, 2025 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC  is investigating securities fraud claims against Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) ("Spectrum" or the "Company") on behalf of investors who purchased or otherwise acquired common shares of Spectrum between  March 17, 2022 through September 22, 2022 (the "Class Period"). Investor Deadline:  Investors who purchased or acquired Spectrum securities during the Class Period may, no later than September 24, 2025 , seek to be appointed as a lead plaintiff representative of the class.

PHILADELPHIA, Aug. 18, 2025 (GLOBE NEWSWIRE) -- National plaintiffs' law firm Berger Montague PC is investigating securities fraud claims against Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) (“Spectrum” or the “Company”) on behalf of investors who purchased or otherwise acquired common shares of Spectrum between March 17, 2022 through September 22, 2022 (the “Class Period”).

PHILADELPHIA , Aug. 13, 2025 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC  is investigating securities fraud claims against Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) ("Spectrum" or the "Company") on behalf of investors who purchased or otherwise acquired common shares of Spectrum between  March 17, 2022 through September 22, 2022 (the "Class Period"). Investor Deadline:  Investors who purchased or acquired Spectrum securities during the Class Period may, no later than September 24, 2025 , seek to be appointed as a lead plaintiff representative of the class.

Assertio (ASRT) came out with a quarterly loss of $0.17 per share versus the Zacks Consensus Estimate of a loss of $0.1. This compares to a loss of $0.04 per share a year ago.

Assertio Holdings, Inc. (NASDAQ:ASRT ) Q2 2025 Earnings Conference Call August 11, 2025 4:30 PM ET Company Participants Ajay Patel - Executive VP & CFO Brendan P. O'Grady - CEO & Director Conference Call Participants Nazibur Rahman - Maxim Group LLC, Research Division Raghuram Selvaraju - H.C.

Second Quarter Total Net Product Sales of $28.8 Million, Cash and Investments Increase to $98.2 Million Narrows Guidance on Continued Progress Implementing Long-Term Business Strategy LAKE FOREST, Ill., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products designed to address patients' needs, today reported financial results for the second quarter ended June 30, 2025.

PHILADELPHIA, Aug. 07, 2025 (GLOBE NEWSWIRE) -- National plaintiffs' law firm Berger Montague PC is investigating securities fraud claims against Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) (“Spectrum” or the “Company”) on behalf of investors who purchased or otherwise acquired common shares of Spectrum between March 17, 2022 through September 22, 2022 (the “Class Period”).